バイエル薬品株式会社に対する報告命令を行いました
https://www.mhlw.go.jp/stf/houdou/0000165950.htmlバイエル薬品株式会社に対する報告命令を行いました
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces that the Ministry of Health, Labour and Welfare issued a reporting order to Bayer Yakuhin Ltd. on May 29, 2017. The order was issued under the Pharmaceutical Affairs Law following the company's disclosure of delayed reporting of 12 adverse event cases for Xarelto (rivaroxaban). The order requires Bayer to investigate all its pharmaceutical products for unreported or delayed adverse event cases and submit a report on the causes of any delays by July 31, 2017.
